Albireo Announces First Patients Dosed in Two New Studies

NEXT STORY
The Worldwide Veterinary Antimicrobial Susceptibility Testing Industry is Expected to Reach $135 Million by 2026
PREV STORY
Global Precision Medicine Market (2021 to 2028) – Demand for Preventive Care Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Iaslc, 폐암 전문의 대상으로 분자 테스트에 대한 글로벌 서베이 실시

흉부 악성종양 분야 리더인 IASLC, 전 세계를 대상으로 분자 테스트를 평가하고 향상시키기 위한 서베이 ...

author_avatar
NASDAQ Market News

Holaira Hosts Educational Symposium on Targeted Lung Denervation (TLD) in Obstructive Lung Disease at ERS

LONDON, UNITED KINGDOM--(Marketwired - Sep 5, 2016) - Holaira, Inc., a developer of medical ...

author_avatar
NASDAQ Market News

Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma

MADISON, Wis., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused ...

author_avatar
NASDAQ Market News